ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Otolaryngology

Top Otolaryngology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVE KIM MD

Otolaryngology

2,012

$102K

693
652 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 29%

$51
Average prescription price

Avg: $68

ARTHUR FERRARI MD

Otolaryngology

1,872

$164K

437
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 29%

$88
Average prescription price

Avg: $68

ALFREDO FESTA M.D.

Otolaryngology

1,533

$117K

759
627 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 29%

$76
Average prescription price

Avg: $68

ROBERT PARK MD

Otolaryngology

1,087

$64.5K

436
356 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $68

EDWARD ENGLE DO

Otolaryngology

1,014

$79.3K

324
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 29%

$78
Average prescription price

Avg: $68

SCOTT KAY MD

Otolaryngology

1,005

$81.7K

271
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $68

WILLIAM DRAKE III M.D.

Otolaryngology

946

$167K

191
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 29%

$177
Average prescription price

Avg: $68

MARY MITSKAVICH M.D.

Otolaryngology

916

$66.4K

290
248 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 29%

$72
Average prescription price

Avg: $68

HERBERT DEUTSCH MD

Otolaryngology

864

$26.4K

287
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 29%

$31
Average prescription price

Avg: $68

MICHAEL SCHERL M.D.

Otolaryngology

805

$47.2K

371
333 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 29%

$59
Average prescription price

Avg: $68

SAMIR SHAH M.D.

Otolaryngology

780

$49K

219
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 29%

$63
Average prescription price

Avg: $68

JAMES BOOZAN M.D.

Otolaryngology

731

$48.6K

263
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $68

BRIAN LEBOVITZ M.D., F.A.C.S.

Otolaryngology

708

$57.9K

178
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 29%

$82
Average prescription price

Avg: $68

FRANK KARDOS M.D

Otolaryngology

685

$36.9K

293
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 29%

$54
Average prescription price

Avg: $68

ADRIANNA HEKIERT MD

Otolaryngology

681

$55.3K

163
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 29%

$81
Average prescription price

Avg: $68

BABAK BEHIN MD

Otolaryngology

664

$44.5K

324
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $68

ROBERT HUANG MD

Otolaryngology

662

$27.9K

263
200 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 29%

$42
Average prescription price

Avg: $68

ASHMIT GUPTA MD

Otolaryngology

657

$59.1K

218
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 29%

$90
Average prescription price

Avg: $68

RONALD LI MD

Otolaryngology

617

$41.3K

223
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 29%

$67
Average prescription price

Avg: $68

RASESH SHAH M.D.

Otolaryngology

608

$22.7K

217
155 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

12%
prescriptions for brand name drugs

Avg: 29%

$37
Average prescription price

Avg: $68

CHARLES SCHULTZ MD

Otolaryngology

571

$47.4K

224
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 29%

$83
Average prescription price

Avg: $68

ANTHONY CULTRARA M.D.

Otolaryngology

570

$46.5K

209
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 29%

$82
Average prescription price

Avg: $68

ZUBAIR SYED D.O

Otolaryngology

567

$26.5K

260
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 29%

$47
Average prescription price

Avg: $68

SEAN HOUSTON M.D.

Otolaryngology

564

$57.6K

224
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 29%

$102
Average prescription price

Avg: $68

JOHN CECE M.D.

Otolaryngology

551

$33.8K

181
153 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 29%

$61
Average prescription price

Avg: $68

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank